Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
TWD 13.6
(-14.73%)
TWD 13.6
(-14.73%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 748.57 Million TWD | 5.91% |
| 2022 | 706.77 Million TWD | -0.98% |
| 2021 | 713.74 Million TWD | -13.32% |
| 2020 | 823.44 Million TWD | 25.7% |
| 2019 | 655.06 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 699.31 Million TWD | -6.58% |
| 2024 Q2 | 699.31 Million TWD | 0.0% |
| 2023 FY | 748.57 Million TWD | 5.91% |
| 2023 Q2 | 710.25 Million TWD | 0.0% |
| 2023 Q1 | 710.25 Million TWD | 0.49% |
| 2023 Q3 | 748.57 Million TWD | 5.39% |
| 2023 Q4 | 748.57 Million TWD | 0.0% |
| 2022 Q3 | 706.77 Million TWD | 0.0% |
| 2022 Q4 | 706.77 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -484.606% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 74.195% |
| Level Biotechnology Inc. | 822.67 Million TWD | 9.007% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -12.614% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -36.414% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 80.776% |
| GlycoNex Incorporation | 1.55 Billion TWD | 51.793% |
| VBI | 452.1 Million TWD | -65.576% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 36.354% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -97.845% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 33.979% |
| Visgeneer Inc. | 397.17 Million TWD | -88.473% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 80.146% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 65.328% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 15.233% |
| Neith Corporation | 192.15 Million TWD | -289.57% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 87.714% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -917.661% |
| Enimmune corporation | 604.82 Million TWD | -23.766% |
| TaiRx, Inc. | 833.74 Million TWD | 10.216% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 75.743% |
| EirGenix Inc. | 11.16 Billion TWD | 93.294% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -30.609% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 56.284% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 79.187% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 28.74% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -148.668% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -182.846% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -69.671% |
| RBC Bioscience Corporation | 753.79 Million TWD | 0.692% |
| BiOptic Inc. | 613.77 Million TWD | -21.962% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 57.914% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 35.452% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -16.085% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 75.901% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -406.017% |
| NaviFUS Corp. | 490.53 Million TWD | -52.603% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 38.928% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 45.094% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -41.468% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 35.545% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 54.804% |
| AP Biosciences Inc | 890.75 Million TWD | 15.962% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 91.221% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -130.935% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 43.87% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 72.388% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 95.128% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -82.463% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -88.628% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 63.94% |
| TCI GENE Inc. | 1.16 Billion TWD | 35.797% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -154.114% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 45.092% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 20.514% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -7.176% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 81.068% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 80.418% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 39.133% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 86.642% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 29.514% |
| Acepodia, Inc. | 6.81 Billion TWD | 89.022% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 80.437% |